TargetLeucine-rich repeat serine/threonine-protein kinase 2(Homo sapiens (Human))
Elan Pharmaceuticals
Curated by ChEMBL
Elan Pharmaceuticals
Curated by ChEMBL
Affinity DataIC50: 338nMAssay Description:Inhibition of wild type LRRK2 (unknown origin) by TR-FRET assayMore data for this Ligand-Target Pair